Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
Biochemical Pharmacology
|
May 25, 1993
Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug action
J Sosinski, J H Thakar, G S Germain, et al.
Indoor Air
|
October 18, 2015
The MERMAID study: indoor and outdoor average pollutant concentrations in 10 low-energy school buildings in France
M Verriele, C Schoemaecker, B Hanoune, et al.
Proceedings of the Clinical Dialysis and Transplant Forum
|
January 1, 1973
Functional difference in transplantation of fragmented renal medulla and monolayer culture of renomedullary interstitial cells
E E Muirhead, G S Germain, B Brooks, et al.
Anticancer Research
|
November 1, 1993
Use of a biotinyl-estradiol derivative to demonstrate estradiol-membrane binding sites on adherent human breast cancer MCF-7 cells
P S Germain, P Metezeau, L X Tiefenauer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1989
Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency
P J Houghton, G S Germain, B J Hazelton, et al.
Blood
|
October 25, 2001
Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells
H Kawabata, T Nakamaki, P Ikonomi, et al.
Oncology Research
|
June 5, 1998
Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells
K N Thimmaiah, B S Jayashree, G S Germain, et al.
The Journal of Biological Chemistry
|
April 5, 2000
Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo
H Kawabata, R S Germain, P T Vuong, et al.
Lupus
|
November 10, 2009
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome
K Bramham, B J Hunt, S Germain, et al.
Cancer Research
|
February 15, 1994
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor
M B Dilling, P Dias, D N Shapiro, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
Biochemical Pharmacology
|
May 25, 1993
Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug action
J Sosinski, J H Thakar, G S Germain, et al.
Indoor Air
|
October 18, 2015
The MERMAID study: indoor and outdoor average pollutant concentrations in 10 low-energy school buildings in France
M Verriele, C Schoemaecker, B Hanoune, et al.
Proceedings of the Clinical Dialysis and Transplant Forum
|
January 1, 1973
Functional difference in transplantation of fragmented renal medulla and monolayer culture of renomedullary interstitial cells
E E Muirhead, G S Germain, B Brooks, et al.
Anticancer Research
|
November 1, 1993
Use of a biotinyl-estradiol derivative to demonstrate estradiol-membrane binding sites on adherent human breast cancer MCF-7 cells
P S Germain, P Metezeau, L X Tiefenauer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1989
Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency
P J Houghton, G S Germain, B J Hazelton, et al.
Blood
|
October 25, 2001
Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells
H Kawabata, T Nakamaki, P Ikonomi, et al.
Oncology Research
|
June 5, 1998
Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells
K N Thimmaiah, B S Jayashree, G S Germain, et al.
The Journal of Biological Chemistry
|
April 5, 2000
Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo
H Kawabata, R S Germain, P T Vuong, et al.
Lupus
|
November 10, 2009
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome
K Bramham, B J Hunt, S Germain, et al.
Cancer Research
|
February 15, 1994
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor
M B Dilling, P Dias, D N Shapiro, et al.
Page
of 9